Zinc inhibits high glucose-induced NLRP3 inflammasome activation in human peritoneal mesothelial cells

Yi Fan1, Xiuli Zhang1, Lina Yang1

  • 1Department of Nephrology, The First Affiliated Hospital, China Medical University, Shenyang, Liaoning 110001, P.R. China.

Insights

Zinc supplementation inhibits high glucose-induced NLRP3 inflammasome activation in human peritoneal mesothelial cells. This occurs by activating the Nrf2 antioxidant pathway, which reduces reactive oxygen species (ROS) production.

Area of Science:

  • Cell Biology
  • Immunology
  • Metabolism

Background:

  • Zinc deficiency is known to activate the NLRP3 inflammasome in macrophages.
  • The role of zinc in NLRP3 inflammasome activation within peritoneal mesothelial cells (PMCs) is not well understood.
  • High glucose conditions can impact cellular functions and inflammatory responses.

Purpose of the Study:

  • To investigate the effect of zinc on high glucose-induced NLRP3 inflammasome activation in human PMCs (HPMCs).
  • To elucidate the underlying mechanisms involving reactive oxygen species (ROS) and the Nrf2 pathway.

Main Methods:

  • Human PMC (HMrSV5) cells were treated with high glucose and either zinc sulfate or a zinc chelator.
  • NLRP3/caspase-1 inflammasome activity was assessed using western blot, immunofluorescence, RT-qPCR, and ELISA.
  • Nuclear factor erythroid 2-related factor 2 (Nrf2) pathway activity and ROS levels were measured via western blotting and flow cytometry.

Main Results:

  • Zinc supplementation significantly inhibited high glucose-induced NLRP3 inflammasome activation in HPMCs.
  • Zinc attenuated the production of reactive oxygen species (ROS) in high glucose-treated HPMCs.
  • Zinc activated the Nrf2 antioxidant pathway, which mediated the reduction in ROS production.

Conclusions:

  • Zinc plays a protective role against high glucose-induced NLRP3 inflammasome activation in HPMCs.
  • The mechanism involves the activation of the Nrf2 antioxidant pathway, leading to decreased ROS levels.
  • These findings highlight the potential of zinc in managing cellular inflammation under high glucose conditions.